Browsing the "patients" Tag

Mesoblast (ASX:MSB) receives ethics approval to treat Covid-19 patients

September 2nd, 2020 📆 | 8210 Views ⚑

Mesoblast (ASX:MSB) today announced that it has received ethics approval to include Australian hospitals in the Phase 3 randomized controlled

Tagged with:




GENFIT Announces Pivotal Publication of NIS4™ Technology to Identify Patients with At-Risk NASH in The Lancet Gastroenterology & Hepatology

August 5th, 2020 📆 | 4275 Views ⚑

Suneil Hosmane, PhD, Head of Global Diagnostics at GENFIT commented: “This publication represents a milestone achievement for our NIS4™ technology.

Tagged with: